Coherus BioSciences, Inc. ( NASDAQ: CHRS) Q4 2024 Earnings Conference Call March 10, 2025 5:00 PM ET Jodi Sievers - Head of IR Denny Lanfear - CEO Paul Reider - CCO Sameer Goregaoker - SVP, ...

Q4 2024 Earnings Call Transcript March 10, 2025 Coherus BioSciences, Inc. misses on earnings expectations. Reported EPS is ...

In a recent study of 78,000 social media posts during the American Society of Clinical Oncology (ASCO) 2015 Annual Meeting, 230 of the most engaged online healthcare professionals were followed by ...

Also announced at ASCO was some intriguing new data on circulating tumour DNA (ctDNA) – fragments of genetic material from cancer cells – that can indicate the presence of minimal residual ...

Risk Stratification Using Tree-Based Models for Recurrence-Free Survival in Breast Cancer In patients with mRCC, Medicare was associated with significantly better survival outcomes compared with ...

BAAR, Switzerland, March 12, 2025--(BUSINESS WIRE)--Exact Sciences, a leading provider of cancer screening and diagnostic tests, today announced the presentation of new data further reinforcing ...

And since then, we’ve had an update on therapeutic results at ASCO GI, and so tracking these patients forward. What we told The Street is that once we have clarity in terms of what we’re ...

– VERITAC-2 achieved its primary endpoint in the estrogen receptor 1-mutant population, demonstrating statistically significant and clinically meaningful improvement in progression-free survival ...

Very Clean 1980 Bell 206BIII Jetranger. Excellent condition New Main Rotor Blades and Van Horn Tail Rotor. Updated custom paint and many accessories kits installed.